51. [Ocular toxoplasmosis - seeking a strategy for treatment].
- Author
-
Prášil P, Plíšek S, and Boštík P
- Subjects
- Adrenal Cortex Hormones administration & dosage, Adult, Anti-Bacterial Agents administration & dosage, Drug Therapy, Combination, Female, Humans, Male, Recurrence, Retrospective Studies, Adrenal Cortex Hormones therapeutic use, Anti-Bacterial Agents therapeutic use, Toxoplasmosis, Ocular drug therapy
- Abstract
Aim: To compare the effectiveness of treatment for ocular toxoplasmosis with pyrimethamine + clindamycin (or sulfadiazine) + a corticoid (Group 1), or azithromycin or a combination of azithromycin with a corticoid or a corticoid alone (Group 2). To determine the relapse rate depending on the treatment approach., Material and Methods: A total of 25 patients treated for ocular toxoplasmosis over the last five years (2008-2013) were analyzed. Group 1 comprised 16 patients (3 were excluded) and Group 2 consisted of 6 patients., Results: Visual improvement was more rapid in Group 1 (day 10.7) than in Group 2 (significant improvement on day 29.6). There were 5 cases of relapse in Group 1; in 13 cases, no relapse was noted; all patients in Group 2 relapsed (a total of 13 relapses). Twenty-three patients were positive for specific IgG antibodies., Conclusion: According to our experiences, pyrimethamine + clindamycin (or sulfadiazine) + a corticoid should be the treatment of choice in patients with ocular toxoplasmosis.
- Published
- 2014